Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Grant or award SVP, Commercial Operations acquired 29,061 shares (grant or award)
  2. 4 Open-market sale Chief People Officer sold 2,000 shares at $33.80 ($67,600)
  3. 4 Open-market sale Chief Financial Officer sold 20,000 shares at an average $32.08 ($641,642)
  4. 4 Open-market sale Chief Scientific Officer sold 7,090 shares at an average $35.58 ($252,247)
  5. 4 Open-market sale Chief Scientific Officer sold 3,895 shares at an average $36.14 ($140,748)
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Open-market sale SVP and General Counsel sold 4,166 shares at $41.93 ($174,680)
  9. DEFA14A Proxy Proxy Materials
  10. DEF 14A Proxy Proxy Statement
  11. 4 Open-market sale Chief Scientific Officer sold 27,265 shares at an average $41.56 ($1,133,212)
  12. 4 Open-market sale SVP, Diagnostics, T-Detect sold 1,301 shares at $41.25 ($53,666)
  13. 4 Open-market sale Chief People Officer sold 2,000 shares at $43.04 ($86,080)
  14. 4 Open-market sale Chief Medical Officer sold 2,000 shares at $44.50 ($89,000)
  15. 4 Open-market sale Director sold 4,500 shares at $43.41 ($195,345)
  16. 4 Open-market sale Chief Operating Officer sold 3,586 shares at $42.34 ($151,831)
  17. 4 Open-market sale Chief Financial Officer sold 20,000 shares at an average $41.30 ($826,005)
  18. 4 Open-market sale CEO and Chairman sold 15,000 shares at an average $41.81 ($627,107)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale SVP and General Counsel sold 4,167 shares at $40.00 ($166,680)

Page 23 of 42 · 837 filings